Imperial Valley News Center
FDA approves Briviact to treat partial onset seizures
- Details
- Written by IVN
Washington, DC - The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.
Diabetes drug may prevent recurring strokes
- Details
- Written by Barbara McMakin
Los Angeles, California - Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention after Stroke (IRIS) trial, presented at the International Stroke Conference 2016 in Los Angeles and published in the New England Journal of Medicine, suggest a potential new method to prevent stroke and heart attack in high-risk patients who have already had one stroke or transient ischemic attack.
NIH Rare Disease Day event, on Leap Day, will feature patients’ voices and international collaboration
- Details
- Written by IVN
Washington, DC - On February 29, NIH will host a Rare Disease Day event to raise awareness about rare diseases, the people they affect and current research collaborations. An estimated 25 million people in the United States have rare diseases. The event will feature presentations, posters, exhibits, an art show and tours of the NIH Clinical Center - a hospital at which researchers are studying nearly 600 rare diseases in partnership with over 15,000 patients. Admission is free and open to the public.
Adderall Misuse Rising Among Young Adults
- Details
- Written by Barbara Benham
Baltimore, Maryland - While the number of prescriptions for the stimulant Adderall has remained unchanged among young adults, misuse and emergency room visits related to the drug have risen dramatically in this group, new Johns Hopkins Bloomberg School of Public Health research suggests.
Industry Initiatives to Prevent Drinking and Driving Lack Scientific Evidence of Effectiveness, Study Suggests
- Details
- Written by Bobbi Nicotera
Baltimore, Maryland - The majority of the alcohol industry’s actions around the world to reduce drinking and driving either lack evidence of effectiveness or haven’t been studied, new Johns Hopkins Bloomberg School of Public Health research suggests.
Mayo Clinic Board Recognizes Retiring Members, Elects New Members
- Details
- Written by Karl W Oestreich
Phoenix, Arizona - The Mayo Clinic Board of Trustees recognized three retiring members, elected new members and re-elected members at its board meeting today.
Page 2500 of 3785